Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 3/20 | 0.46 |
| ▸ | KDM1A | O60341 | 2/20 | 0.46 |
| ▸ | JAK2 | O60674 | 3/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | PSEN1 | P49768 | 4/20 | 0.42 |
| ▸ | PSEN2 | P49810 | 4/20 | 0.42 |
| ▸ | APH1B | Q8WW43 | 4/20 | 0.42 |
| ▸ | NCSTN | Q92542 | 4/20 | 0.42 |
| ▸ | APH1A | Q96BI3 | 4/20 | 0.42 |
| ▸ | PSENEN | Q9NZ42 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.41 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.41 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
| ▸ | WNT3A | P56704 | 1/20 | 0.41 |
| ▸ | PLOD2 | O00469 | 1/20 | 0.41 |
| ▸ | PLOD3 | O60568 | 1/20 | 0.41 |
| ▸ | PLOD1 | Q02809 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5956493 | 0.89 | HDAC1 (0.46) | HDAC1JAK2 | |
| SCHEMBL5956591 | 0.89 | WNT3A (0.45) | HDAC1KDM1AWNT3ANPC1MAPT | |
| SCHEMBL5956496 | 0.88 | HPGD (0.50) | AOC3NPC1GAARAB9A | |
| SCHEMBL5956548 | 0.86 | HDAC1 (0.48) | HDAC1KDM1ALMNABRD9BAZ2B | |
| SCHEMBL5956509 | 0.82 | IRAK4 (0.41) | WNT3AKDM4EMAPT | |
| SCHEMBL5907452 | 0.80 | HDAC1 (0.50) | HDAC1KDM1AJAK2ADORA2AADORA1 | |
| SCHEMBL5956662 | 0.80 | LOXL2 (0.55) | WNT3AKDM4ENPC1GAARAB9A | |
| SCHEMBL5956490 | 0.80 | WNT3A (0.39) | HDAC1KDM1APSEN1PSEN2APH1B | |
| SCHEMBL5956479 | 0.80 | TGFBR1 (0.57) | — | |
| SCHEMBL5956440 | 0.79 | WNT3A (0.43) | HDAC1KDM1AADORA2AADORA1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050014730-A1 | Anti-fungal formulation of triterpene and essential oil | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2005-01-20 | — | — | US | claimed |
| WO-2004089357-A2 | ANTI-FUNGAL FORMULATION OF TRITERPENE AND ESSENTIAL OIL | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2004-10-21 | — | — | WO | claimed |
| US-20040097436-A1 | Triterpenes having antibacterial activity | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2004-05-20 | — | — | US | claimed |
| US-6689767-B2 | TRITERPENE BACTERICIDES | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2004-02-10 | — | — | US | claimed |
| EP-1322661-A1 | TRITERPENES HAVING FUNGICIDAL ACTIVITY AGAINST YEAST | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2003-07-02 | — | — | EP | claimed |
| US-20020128210-A1 | Triterpenes having human antifungal and antiyeast activity | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2002-09-12 | — | — | US | claimed |
| US-20020119935-A1 | Triterpenes having antibacterial activity | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2002-08-29 | — | — | US | claimed |
| WO-2002026762-A1 | TRITERPENES HAVING ANTIBACTERIAL ACTIVITY | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2002-04-04 | — | — | WO | claimed |
| WO-2002026761-A1 | TRITERPENES HAVING FUNGICIDAL ACTIVITY AGAINST YEAST | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2002-04-04 | — | — | WO | claimed |
| EP-1543003-B1 | IMIDAZO¬1,2-A|PYRIDINES | SMITHKLINE BEECHAM CORP (US) | 2006-05-17 | — | — | EP | disclosed |
| US-20060004051-A1 | Compounds | DODIC NERINA | 2006-01-05 | — | — | US | disclosed |
| US-20060003948-A1 | Compositions that include a triterpene and a carrier | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2006-01-05 | — | — | US | disclosed |
| US-20050234029-A1 | Compounds | DODIC NERINA | 2005-10-20 | — | — | US | disclosed |
| WO-2005077377-A1 | COMPOSITIONS THAT INCLUDE A TRITERPENE AND A CARRIER | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2005-08-25 | — | — | WO | disclosed |
| US-6642217-B2 | Treating a fungal or yeast infection such as with betulin, allobetulin, and lupeol | NATURTEK, LLC | 2003-11-04 | — | — | US | disclosed |
| EP-1322661-A1 | TRITERPENES HAVING FUNGICIDAL ACTIVITY AGAINST YEAST | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2003-07-02 | — | — | EP | disclosed |
| US-20020128210-A1 | Triterpenes having human antifungal and antiyeast activity | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2002-09-12 | — | — | US | disclosed |
| US-20020119935-A1 | Triterpenes having antibacterial activity | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2002-08-29 | — | — | US | disclosed |
| WO-2002026762-A1 | TRITERPENES HAVING ANTIBACTERIAL ACTIVITY | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2002-04-04 | — | — | WO | disclosed |
| WO-2002026761-A1 | TRITERPENES HAVING FUNGICIDAL ACTIVITY AGAINST YEAST | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2002-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128210-A1 | Triterpenes having human antifungal and antiyeast activity | ERG28, LSS, MANBA | HDAC1 3700/4885KDM1A 4714/4885JAK2 4728/4885 |
| US-20050234029-A1 | Compounds | SMAD3, SMAD2, ACVR1 | HDAC1 652/4885KDM1A 2364/4885JAK2 221/4885 |
| US-20050014730-A1 | Anti-fungal formulation of triterpene and essential oil | BET1, VRK1, VRK2 | HDAC1 2247/4885KDM1A 2445/4885JAK2 1401/4885 |
| US-20040097436-A1 | Triterpenes having antibacterial activity | BET1, PGGT1B, LSS | HDAC1 2429/4885KDM1A 4791/4885JAK2 4353/4885 |
| US-20060004051-A1 | Compounds | SMAD3, SMAD2, TGFBR1 | HDAC1 1234/4885KDM1A 2586/4885JAK2 177/4885 |
| US-20060003948-A1 | Compositions that include a triterpene and a carrier | PGGT1B, BET1, CYP51A1 | HDAC1 1265/4885KDM1A 3410/4885JAK2 4645/4885 |
| US-20020119935-A1 | Triterpenes having antibacterial activity | BET1, PGGT1B, LSS | HDAC1 2429/4885KDM1A 4791/4885JAK2 4353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.